GlassScriptPhysician profile
Michael O Meyers
NPI 1700971090
$8,583.98
in general payments reported to CMS, 2019-2025
10 companies · $261 in 2025
The $261 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.56 · 2020: $157 · 2021: $96.46 · 2022: $199 · 2023: $7,793 · 2024: $22.71 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,750 · Travel and Lodging: $772 · Food and Beverage: $554.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,750.00 |
| Travel and Lodging | $772.26 |
| Food and Beverage | $554.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $7,607.19 | 2023 | |
| Ethicon US, LLC | $308.82 | 2020-2023 | Certus 140, Harmonic |
| Intuitive Surgical, INC. | $190.38 | 2021-2022 | |
| Baxter Healthcare | $130.69 | 2025 | Tisseel |
| Caris Mpi, INC. | $130.28 | 2025 | Mi Cancer Seek |
| Stryker Corporation | $104.73 | 2022 | |
| Covidien LP | $55.56 | 2019 | |
| Abiomed | $22.71 | 2024 | Impella |
| Vioptix INC | $20.08 | 2020 | |
| Integra Lifesciences Corporation | $13.54 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Meyers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.